Dynamic SPECT in two healthy volunteers to determine the optimal time for in vivo D2 dopamine receptor imaging with 123I-IBZM using the rotating gamma camera
- PMID: 1838141
- DOI: 10.1097/00006231-199108000-00004
Dynamic SPECT in two healthy volunteers to determine the optimal time for in vivo D2 dopamine receptor imaging with 123I-IBZM using the rotating gamma camera
Abstract
Dynamic SPECT was performed in two healthy male volunteers with a single slice brain dedicated camera (Strichman Medical Equipment 810, first study) and a rotating gamma camera (Siemens Dual Rota ZLC37, second study) to obtain information about the optimal imaging time for the dopamine D2 receptor specific ligand 123I-(S)-(-)-2-hydroxy-3-iodo-6-methoxy-N[(1-ethyl-2-pyrrolidinyl) methyl]-benzamide (123I-IBZM). Count rates in the basal ganglia and in several cerebral cortical regions were used to define specific and aspecific binding, respectively. On the basis of the first study, 90-150 min seemed the optimal time for rotating gamma camera 123I-IBZM-SPECT. On the basis of the second study the optimal period was considered to be 60-120 min. It is recommended to apply the same imaging time after injection in a protocol to all patients and volunteers as otherwise a comparison may not be reliable.
Similar articles
-
Dopamine D2 receptor SPECT imaging: basic in vivo characteristics and clinical applications of 123I-IBZM in humans.Ann Nucl Med. 1993 Feb;7(1):29-38. doi: 10.1007/BF03164789. Ann Nucl Med. 1993. PMID: 8461237
-
SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease.Nucl Med Commun. 1991 Aug;12(8):699-707. doi: 10.1097/00006231-199108000-00005. Nucl Med Commun. 1991. PMID: 1838142
-
Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.Neuroimage. 2005 Feb 1;24(3):822-31. doi: 10.1016/j.neuroimage.2004.10.005. Epub 2004 Nov 24. Neuroimage. 2005. PMID: 15652317
-
D2-receptor imaging with [123I]IBZM and single photon emission tomography in psychiatry: a survey of current status.J Neural Transm Gen Sect. 1995;99(1-3):173-85. doi: 10.1007/BF01271477. J Neural Transm Gen Sect. 1995. PMID: 8579803 Review.
-
Diagnostic imaging of dopamine receptors in pituitary adenomas.Eur J Endocrinol. 2007 Apr;156 Suppl 1:S53-S56. doi: 10.1530/eje.1.02349. Eur J Endocrinol. 2007. PMID: 17413189 Review.
Cited by
-
Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH/PRL-producing pituitary macroadenoma.Eur J Nucl Med. 1993 Jun;20(6):555-61. doi: 10.1007/BF00175168. Eur J Nucl Med. 1993. PMID: 8339737
-
Dosimetry of iodine-123 iodobenzamide in healthy volunteers.Eur J Nucl Med. 1993 Sep;20(9):747-52. doi: 10.1007/BF00180903. Eur J Nucl Med. 1993. PMID: 8223767
-
Dopamine D2 receptor SPECT imaging: basic in vivo characteristics and clinical applications of 123I-IBZM in humans.Ann Nucl Med. 1993 Feb;7(1):29-38. doi: 10.1007/BF03164789. Ann Nucl Med. 1993. PMID: 8461237
-
IBZM tool: a fully automated expert system for the evaluation of IBZM SPECT studies.Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1073-83. doi: 10.1007/s00259-006-0067-9. Epub 2006 Apr 14. Eur J Nucl Med Mol Imaging. 2006. PMID: 16614812
-
A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.J Psychiatry Neurosci. 1997 Jan;22(1):39-45. J Psychiatry Neurosci. 1997. PMID: 9002391 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources